Three compounds that share specific antimitochondrial prop- 
Introduction
Cancer cells, like normal cells, derive their cellular energy from ATP generated either by mitochondrial respiration and oxidative phosphorylation or by glycolysis and the degradation of simple carbohydrates to lactic acid. In 1930 Warburg first described the ability of normal cells to reduce glycolysis and lactic acid production in the presence of oxygen (1) . Known as the Pasteur effect, this important form of multienzyme control is believed to originate from mitochondrial signals. Warburg also noted that cancer cells lack this regulatory control over lactic acid production and he postulated that the neoplastic process is induced by some impairment in mitochondrial respiration (2) .
Although few investigators currently believe that malignant transformation originates from within mitochondria, Warburg's hypothesis generated great interest in the study ofmitochondrial function. Presently, a number of associated features are known tember 1986. to differentiate normal from malignant mitochondria, and these are reviewed by Pederson (3) . Among these distinguishing features is a frequently observed isozyme shift by oxidoreductases such as lactic dehydrogenase, (LDH,' L-lactate: NAD oxidoreductase, EC 1.1.1.27) (3, 4) . Such isozyme shifts favor enhanced ATP production under anaerobic conditions and reduced feedback regulation over glycolysis. For example, increased content of the cathodal isozyme, LDH5, is observed in both sera and tumor samples of patients with advanced epithelial neoplasms (5) (6) (7) (8) . Another feature of malignant transformation is the augmented transmembrane potential within malignant mitochondria. This results in increased mitochondrial retention of lipophilic cationic dyes such as rhodamine-123 (9) .
Recently, investigators have theorized that the differences between normal and malignant mitochondria might be exploited in the development of mitochondrial-specific antitumor agents (10) . Three unique compounds that might now be classified as antimitochondrial agents include the supravital dye, rhodamine-123, the phenolic cotton seed (Gossypium) extract, gossypol, and the indazole carboxylic acid, lonidamine. These compounds are shown in Fig. 1 .
The antitumor potential of rhodamine-123 was recognized shortly after its identification as a fluorescent mitochondrial dye ( I1-13). Gossypol and lonidamine were initially developed as antispermatogenic compounds; both are currently being tested for antitumor activity (14, 15) . These three agents share common dose-dependent properties: enhanced accumulation into tumor mitochondria, inhibition of oxidoreductases and uncoupling of mitochondrial respiration, reduction in intracellular oxygen consumption and lactic acid production, and swelling of mitochondria followed by cytoplasmic leakage and decreased cellular synthesis of macromolecules.
Preliminary results indicate that the antitumor toxicity of these agents is very selective (13, 14, 16) , perhaps explaining the failure of early screening procedures to detect their potential chemotherapeutic application (17). In this report we identify a simple assay that may be helpful in identifying tumors most sensitive to antimitochondrial agents. We also compare the antitumor activity of these three drugs with their ability to inhibit clonogenic growth of normal human bone marrow stem cells.
In addition, we demonstrate the potential ability of31P magnetic resonance spectroscopy to provide a noninvasive means of monitoring the biochemical changes induced by a toxic dose of either gossypol or rhodamine-123.
Methods
Growth inhibition ofhuman tumor cell lines and bone marrow stem cells. The well-established monolayer human carcinoma cell lines T47-D (21) . The agarose gel electrophoresis and fluorometric detection ofLDH isozymes is performed on a Corning Medical and Scientific (Palo Alto, CA) system using -4,000 U/I of LDH-containing lysate, with AMP lactate (pH 9.0) and NAD as substrates. Gels are photographed and densitometrically scanned under UV illumination for detection and quantitation of the five tetrameric LDH isozymes, as well as the unique germ cell-specific isozyme LDHC4, also known as LDH-X (21). Human serum and lysate from sperm-containing ejaculate are used as assay standards, demonstrated in Fig. 2 . Scanned peaks of isozyme activity are quantitated as percent total LDH activity with a Beckman Model R-11O densitometer and integrator. For regression analysis, the percent of cathodal isozyme activity is calculated as either the combined percentage of LDH4 + LDH5 activity, or by determining the total percent of the LDH-M monomer using the formula (8) 31P magnetic resonance spectroscopy. All spectroscopy experiments are carried out on a system consisting of a 5.6-tesla superconducting magnet using a 31P resonance frequency of 97.59 MHz, a Nicolet computer (NIC 1180), and customized transmitter, receiver, filter, and preamplifiers. A typical spectrum is obtained using 60'-radiofrequency pulses over a 10-KHz sweep width, a recycle time of 2.2 s, quadrature detection over 4K data points in -30 min, and exponential line broadening of 30 Hz. Spectra are referenced to an internal capillary containing methylenediphosphonic acid (0.5 M) in a Tris buffer (pH 7.4) at a run temperature of 4VC. Control or drug-treated cells (108) that remain intact and attached as monolayers are harvested by trypsinization, rinsed with 0.9% NaCl containing 20 mM Tris HCI (pH 7.5) and 3 mM MgCl2, loosely pelleted and placed into a 10-mm diameter glass tube within the homogeneous region of the magnetic field. Control studies have shown that neither cell viability (by trypan blue dye exclusion or plating efficiency) nor phosphorus spectra are significantly altered if spectroscopy is completed within 90 min of culture harvest under these conditions. Beyond 120 min, however, there is a noticeable decline in the f3-ATP spectral peak intensity and a concomitant increase in the inorganic phosphate (Pi) peak intensity. Spectral shifts are identified with respect to phosphocreatine (0 ppm) and conform with previous reports (22) (23) (24) . Intracellular pH is determined from the Pi shift and calculated from a standard curve (25 Fig. 2 gives the calculated distribution of isozyme activities beneath the densitometric profiles and compares the individual tumor cell lines with a serum standard and an extract from human spermatozoa, which contain an abundance (60%) of the unique LDH-X isozyme. The two pancreatic adenocarcinomas, Fig. 6 A, a positive linear regression exists between drug resistance (increased IC50) and anodal isozymes (LDH, + LDH2) for both antimitochondrial agents. Likewise, Fig. 6 (12-14, 26, 27) . While the underlying molecular mechanisms (33) .
The selectivity of gossypol's antitumor activity is confirmed by our results using a variety of common epithelial tumor lines not previously tested. The observed in vitro dependence of this drug's activity on serum content has also been recognized in nonmalignant cell systems (29) . When experiments are controlled for serum content, the antitumor effectiveness ofgossypol does not correlate with tumor type or with cellular growth rates in culture. While this lack ofcorrelation with tumor growth rate is consistent with a prior report on gossypol cytotoxicity ( 16) , it is an unusual observation for an S phase-specific drug (26) (35) .
This study also illustrates the feasibility of 31P magnetic resonance spectroscopy to detect prelethal changes in high-energy phosphate pools occurring in sensitive tumor cells within the first 24 h of exposure to gossypol or rhodamine-123. In preliminary studies with combined magnetic resonance proton imaging and 31p spectroscopy of tumors implanted in rats, we have been able to document that these same spectroscopic perturbations occur in vivo within 3 h following a single injection of gossypol (36) . These preclinical results provide reason to speculate that antimitochondrial agents could ultimately be administered on the basis of an individual tumor's biochemical profile and clinically monitored for effectiveness within the first few hours of their administration.
